First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group-Reference-Cited by-同舟云学术

First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group

Published:2011-03-15 Issue:5 Volume:68 Page:1173-1178
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Pelzer Uwe,Arnold Dirk,Reitzig Peter,Herrenberger Julia,Korsten Friedrich Wilhelm,Kindler Manfred,Stieler Jens,Dörken Bernd,Riess Hanno,Oettle Helmut

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-011-1602-3.pdf

Reference21 articles.

1. Stathis A, Moore MJ (2010) Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 7(3):163–172

2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249

3. Bozzetti F (2009) Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 17(3):279–284

4. Pelzer U, Arnold D, Gövercin M, Stieler J, Doerken B, Riess H, Oettle H (2010) Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study. BMC Cancer 10:86

5. Burris HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403–2413

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Phase II Trial Design in Advanced Pancreatic Cancer;Pancreas;2019-11

2. Currently available first-line drug therapies for treating pancreatic cancer;Expert Opinion on Pharmacotherapy;2018-10-16

3. Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers;Expert Opinion on Investigational Drugs;2015-03-25

4. Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance;Molecules;2014-09-04

5. A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer;Cancer Chemotherapy and Pharmacology;2014-08-21